These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18320092)

  • 1. Controlled off-label use of recombinant activated factor VII (NovoSeven) can build evidence base.
    Cardiovasc J Afr; 2008; 19(1):52-4. PubMed ID: 18320092
    [No Abstract]   [Full Text] [Related]  

  • 2. [Application of activated recombinant factor VII (rFVIIa, NovoSeven) in neonatology].
    Georgieva R
    Akush Ginekol (Sofiia); 2008; 47(3):46-50. PubMed ID: 18756832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular injury and thrombotic potential: a note of caution about recombinant factor VIIa.
    Mazer CD; Leong-Poi H; Mahoney J; Latter D; Strauss BH; Teitel JM
    Semin Cardiothorac Vasc Anesth; 2007 Dec; 11(4):261-4. PubMed ID: 18270189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiographic documentation of the efficacy of recombinant activated factor VII (NovoSeven) to control diffuse bleeding in major trauma.
    Van Der Schueren B; Hammer F; Verschuren F; Hantson P; Deneys V; Hermans C
    Thromb Haemost; 2005 Dec; 94(6):1327-8. PubMed ID: 16411413
    [No Abstract]   [Full Text] [Related]  

  • 5. Factor VIIa: mounting evidence or anecdotal reports.
    Maclaren R
    J Postgrad Med; 2007; 53(1):4-5. PubMed ID: 17244960
    [No Abstract]   [Full Text] [Related]  

  • 6. Formulary management of recombinant factor VIIa at an academic medical center.
    Owen PS; Golightly LK; MacLaren R; Ferretti KA; Badesch DB
    Ann Pharmacother; 2008 Jun; 42(6):771-6. PubMed ID: 18477731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid reversal of anticoagulant bleeding- rFVIIa an option?
    Zupancic-Salek S
    J Postgrad Med; 2007; 53(1):3-4. PubMed ID: 17244959
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison between recombinant activated factor VII (Aryoseven) and Novoseven in patients with congenital factor VII deficiency.
    Faranoush M; Abolghasemi H; Toogeh G; Karimi M; Eshghi P; Managhchi M; Hoorfar H; Dehdezi BK; Mehrvar A; Khoeiny B; Kamyar K; Heshmat R; Baghaeipour MR; Mirbehbahani NB; Fayazfar R; Ahmadinejad M; Naderi M
    Clin Appl Thromb Hemost; 2015 Nov; 21(8):724-8. PubMed ID: 24651301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study.
    Hoffmann T; Assmann A; Dierksen A; Roussel E; Ullrich S; Lichtenberg A; Albert A; Sixt S
    J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1564-1573.e8. PubMed ID: 29884487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor treatment: state of the art.
    Shapiro A
    Dis Mon; 2003 Jan; 49(1):22-38. PubMed ID: 12525826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.
    Hauser CJ; Boffard K; Dutton R; Bernard GR; Croce MA; Holcomb JB; Leppaniemi A; Parr M; Vincent JL; Tortella BJ; Dimsits J; Bouillon B;
    J Trauma; 2010 Sep; 69(3):489-500. PubMed ID: 20838118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Using recombinant activated blood coagulation factor VII for treatment of hemorrhagic syndrome in patients with thrombocytopenia].
    Galstian GM; Kolosova IV
    Anesteziol Reanimatol; 2014; 59(6):60-6. PubMed ID: 25831706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation.
    Mariani G; Napolitano M; Dolce A; Pérez Garrido R; Batorova A; Karimi M; Platokouki H; Auerswald G; Bertrand AM; Di Minno G; Schved JF; Bjerre J; Ingerslev J; Sørensen B; Ruiz-Saez A; ;
    Thromb Haemost; 2013 Feb; 109(2):238-47. PubMed ID: 23238632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Using recombinant activated coagulation factor VII (NovoSeven) in obstetrics].
    Pekhlivanov B; Milchev N; Abrashev B
    Akush Ginekol (Sofiia); 2003; 42(6):7-9. PubMed ID: 15067806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological, clinical, and therapeutic aspects of primary intracerebral hemorrhage.
    Ciccone A; Pozzi M; Motto C; Tiraboschi P; Sterzi R
    Neurol Sci; 2008 Sep; 29 Suppl 2():S256-7. PubMed ID: 18690510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study.
    Hay CR; Negrier C; Ludlam CA
    Thromb Haemost; 1997 Dec; 78(6):1463-7. PubMed ID: 9423795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect.
    Morfini M; Batorova A; Mariani G; Auerswald G; Bernardi F; Di Minno G; Dolce A; Fede C; Giansily-Blaizot M; Ingerslev J; Martinowitz U; Napolitano M; Pinotti M; Schved JF;
    Thromb Haemost; 2014 Aug; 112(2):424-5. PubMed ID: 24763923
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recombinant activated Factor VII (Novo Seven) for uncontrollable hemorrhage in critically ill patients with multiple injuries].
    Pernazza F; Olearis A
    Minerva Chir; 2004 Apr; 59(2):XVII-XIX. PubMed ID: 15455479
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII.
    Tokgoz H; Caliskan U; Lavigne-Lissalde G; Giansily-Blaizot M
    Haemophilia; 2012 Jan; 18(1):e25-7. PubMed ID: 21973016
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.